Skip to main content
. 2017 Aug 23;8(14):2785–2792. doi: 10.7150/jca.19631

Figure 4.

Figure 4

Kaplan-Meier survival curve comparing NSCLC patients with β-arr2High/CXCR2Low expression (n=36) and those with β-arr2Low/CXCR2High expression (n=38) in metastatic lymph nodes. The β-arr2Low/CXCR2High group had significantly worse 4-year overall survival (Log-rank: χ2=5.926, P=0.015).